SMARCB1 and neurofibroma: However, germline testing was negative for NF2 mutation, and sequencing of tumors revealed wild-type NF2. Somatic next-generation sequencing of the spinal schwannoma-neurofibroma showed an isolated SMARCB1 mutation, suggesting a possible unique somatic oncologic driver.